What is TRIOMICS?
Triomics operates at the intersection of healthcare technology and enterprise data management. The company is dedicated to powering next-generation applications that facilitate the seamless exchange and utilization of clinical data. By harnessing the growing maturity of the US healthcare system's adoption of Fast Healthcare Interoperability Resources (FHIR), Triomics addresses critical limitations in current data silos. Its platform serves as a foundational layer for healthcare organizations, enabling them to optimize their FHIR adoption journey and unlock actionable insights from complex datasets. This focus on interoperability and data integrity positions Triomics as a vital partner for research-driven healthcare entities seeking to streamline operations and improve patient outcomes through digital transformation.
How much funding has TRIOMICS raised?
TRIOMICS has raised a total of $37M across 2 funding rounds:
Series A
$15M
Series B
$22M
Series A (2024): $15M with participation from Nexus Venture Partners, Y Combinator, Lightspeed, and General Catalyst
Series B (2026): $22M led by Battery Ventures, Y Combinator, Lightspeed Venture Partners, and Nexus Venture Partners
Key Investors in TRIOMICS
Battery Ventures
A global investment firm that partners with entrepreneurs to build and scale category-defining technology businesses through strategic guidance and capital.
Y Combinator
A prominent startup accelerator and venture capital firm that provides early-stage funding and mentorship to high-growth technology companies.
Lightspeed Venture Partners
A global multistage venture capital firm that invests in early and growth-stage technology companies across enterprise software, fintech, and infrastructure sectors.
What's next for TRIOMICS?
Looking ahead, Triomics is poised to leverage its recent capital influx to scale its enterprise-grade solutions. The strategic focus will likely center on deepening its integration capabilities within existing clinical workflows and expanding its market reach to larger healthcare networks. As the industry continues to prioritize data-driven decision-making, Triomics' ability to bridge the gap between legacy systems and modern FHIR-based architectures will be a key driver of its long-term growth. The company is expected to invest heavily in talent acquisition and technical infrastructure to maintain its competitive edge, ensuring that it remains at the forefront of the digital health revolution while navigating the complexities of large-scale enterprise deployment.
See full TRIOMICS company page
